Nephros (NEPH) Net Margin Growth (3y) (2013 - 2026)
Nephros (NEPH) Net Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 420.00 |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -45.00 |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 573.00 |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -296.00 |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -1,125.00 |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -1,174.00 |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 1,603.00 |
| 10 | Nephros | 45.71 Mn | 41.01 Mn | 4.03 Mn | 3,211.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3,211.00 |
| Mar 31, 2026 | 883.00 |
| Dec 31, 2025 | 3,720.00 |
| Sep 30, 2025 | 14,120.00 |
| Jun 30, 2025 | 4,757.00 |
| Mar 31, 2025 | 7,559.00 |
| Dec 31, 2024 | 5,006.00 |
| Sep 30, 2024 | 5,260.00 |
| Jun 30, 2024 | 4,345.00 |
| Mar 31, 2024 | 1,588.00 |
| Dec 31, 2023 | 1,503.00 |
| Sep 30, 2023 | 4,568.00 |
| Jun 30, 2023 | 9,666.00 |
| Mar 31, 2023 | 3,747.00 |
| Dec 31, 2022 | -2,940.00 |
| Sep 30, 2022 | -10,814.00 |
| Jun 30, 2022 | 123.00 |
| Mar 31, 2022 | -1,443.00 |
| Dec 31, 2021 | 4.00 |
| Sep 30, 2021 | -1,596.00 |